1 Study Coverage
    1.1 Therapeutic Nuclear Medicines Product Introduction
    1.2 Market by Type
        1.2.1 Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Radium-223
        1.2.3 Lutetium-177
        1.2.4 Iodine-131
        1.2.5 Other
    1.3 Market by Application
        1.3.1 Global Therapeutic Nuclear Medicines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Thyroid
        1.3.3 Bone Metastasis
        1.3.4 Lymphoma
        1.3.5 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Therapeutic Nuclear Medicines Sales Estimates and Forecasts 2017-2028
    2.2 Global Therapeutic Nuclear Medicines Revenue Estimates and Forecasts 2017-2028
    2.3 Global Therapeutic Nuclear Medicines Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Therapeutic Nuclear Medicines Sales by Region
        2.4.1 Global Therapeutic Nuclear Medicines Sales by Region (2017-2022)
        2.4.2 Global Sales Therapeutic Nuclear Medicines by Region (2023-2028)
    2.5 Global Therapeutic Nuclear Medicines Revenue by Region
        2.5.1 Global Therapeutic Nuclear Medicines Revenue by Region (2017-2022)
        2.5.2 Global Therapeutic Nuclear Medicines Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Therapeutic Nuclear Medicines Sales by Manufacturers
        3.1.1 Global Top Therapeutic Nuclear Medicines Manufacturers by Sales (2017-2022)
        3.1.2 Global Therapeutic Nuclear Medicines Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Therapeutic Nuclear Medicines in 2021
    3.2 Global Therapeutic Nuclear Medicines Revenue by Manufacturers
        3.2.1 Global Therapeutic Nuclear Medicines Revenue by Manufacturers (2017-2022)
        3.2.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Therapeutic Nuclear Medicines Revenue in 2021
    3.3 Global Therapeutic Nuclear Medicines Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Therapeutic Nuclear Medicines Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Therapeutic Nuclear Medicines Sales by Type
        4.1.1 Global Therapeutic Nuclear Medicines Historical Sales by Type (2017-2022)
        4.1.2 Global Therapeutic Nuclear Medicines Forecasted Sales by Type (2023-2028)
        4.1.3 Global Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2028)
    4.2 Global Therapeutic Nuclear Medicines Revenue by Type
        4.2.1 Global Therapeutic Nuclear Medicines Historical Revenue by Type (2017-2022)
        4.2.2 Global Therapeutic Nuclear Medicines Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2017-2028)
    4.3 Global Therapeutic Nuclear Medicines Price by Type
        4.3.1 Global Therapeutic Nuclear Medicines Price by Type (2017-2022)
        4.3.2 Global Therapeutic Nuclear Medicines Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Therapeutic Nuclear Medicines Sales by Application
        5.1.1 Global Therapeutic Nuclear Medicines Historical Sales by Application (2017-2022)
        5.1.2 Global Therapeutic Nuclear Medicines Forecasted Sales by Application (2023-2028)
        5.1.3 Global Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2028)
    5.2 Global Therapeutic Nuclear Medicines Revenue by Application
        5.2.1 Global Therapeutic Nuclear Medicines Historical Revenue by Application (2017-2022)
        5.2.2 Global Therapeutic Nuclear Medicines Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2017-2028)
    5.3 Global Therapeutic Nuclear Medicines Price by Application
        5.3.1 Global Therapeutic Nuclear Medicines Price by Application (2017-2022)
        5.3.2 Global Therapeutic Nuclear Medicines Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Therapeutic Nuclear Medicines Market Size by Type
        6.1.1 North America Therapeutic Nuclear Medicines Sales by Type (2017-2028)
        6.1.2 North America Therapeutic Nuclear Medicines Revenue by Type (2017-2028)
    6.2 North America Therapeutic Nuclear Medicines Market Size by Application
        6.2.1 North America Therapeutic Nuclear Medicines Sales by Application (2017-2028)
        6.2.2 North America Therapeutic Nuclear Medicines Revenue by Application (2017-2028)
    6.3 North America Therapeutic Nuclear Medicines Market Size by Country
        6.3.1 North America Therapeutic Nuclear Medicines Sales by Country (2017-2028)
        6.3.2 North America Therapeutic Nuclear Medicines Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Therapeutic Nuclear Medicines Market Size by Type
        7.1.1 Europe Therapeutic Nuclear Medicines Sales by Type (2017-2028)
        7.1.2 Europe Therapeutic Nuclear Medicines Revenue by Type (2017-2028)
    7.2 Europe Therapeutic Nuclear Medicines Market Size by Application
        7.2.1 Europe Therapeutic Nuclear Medicines Sales by Application (2017-2028)
        7.2.2 Europe Therapeutic Nuclear Medicines Revenue by Application (2017-2028)
    7.3 Europe Therapeutic Nuclear Medicines Market Size by Country
        7.3.1 Europe Therapeutic Nuclear Medicines Sales by Country (2017-2028)
        7.3.2 Europe Therapeutic Nuclear Medicines Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Therapeutic Nuclear Medicines Market Size by Type
        8.1.1 Asia Pacific Therapeutic Nuclear Medicines Sales by Type (2017-2028)
        8.1.2 Asia Pacific Therapeutic Nuclear Medicines Revenue by Type (2017-2028)
    8.2 Asia Pacific Therapeutic Nuclear Medicines Market Size by Application
        8.2.1 Asia Pacific Therapeutic Nuclear Medicines Sales by Application (2017-2028)
        8.2.2 Asia Pacific Therapeutic Nuclear Medicines Revenue by Application (2017-2028)
    8.3 Asia Pacific Therapeutic Nuclear Medicines Market Size by Region
        8.3.1 Asia Pacific Therapeutic Nuclear Medicines Sales by Region (2017-2028)
        8.3.2 Asia Pacific Therapeutic Nuclear Medicines Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Therapeutic Nuclear Medicines Market Size by Type
        9.1.1 Latin America Therapeutic Nuclear Medicines Sales by Type (2017-2028)
        9.1.2 Latin America Therapeutic Nuclear Medicines Revenue by Type (2017-2028)
    9.2 Latin America Therapeutic Nuclear Medicines Market Size by Application
        9.2.1 Latin America Therapeutic Nuclear Medicines Sales by Application (2017-2028)
        9.2.2 Latin America Therapeutic Nuclear Medicines Revenue by Application (2017-2028)
    9.3 Latin America Therapeutic Nuclear Medicines Market Size by Country
        9.3.1 Latin America Therapeutic Nuclear Medicines Sales by Country (2017-2028)
        9.3.2 Latin America Therapeutic Nuclear Medicines Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Therapeutic Nuclear Medicines Market Size by Type
        10.1.1 Middle East and Africa Therapeutic Nuclear Medicines Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Therapeutic Nuclear Medicines Revenue by Type (2017-2028)
    10.2 Middle East and Africa Therapeutic Nuclear Medicines Market Size by Application
        10.2.1 Middle East and Africa Therapeutic Nuclear Medicines Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Therapeutic Nuclear Medicines Revenue by Application (2017-2028)
    10.3 Middle East and Africa Therapeutic Nuclear Medicines Market Size by Country
        10.3.1 Middle East and Africa Therapeutic Nuclear Medicines Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Therapeutic Nuclear Medicines Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Novartis AG
        11.1.1 Novartis AG Corporation Information
        11.1.2 Novartis AG Overview
        11.1.3 Novartis AG Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Novartis AG Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Novartis AG Recent Developments
    11.2 Bayer
        11.2.1 Bayer Corporation Information
        11.2.2 Bayer Overview
        11.2.3 Bayer Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Bayer Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Bayer Recent Developments
    11.3 China Isotope & Radiation
        11.3.1 China Isotope & Radiation Corporation Information
        11.3.2 China Isotope & Radiation Overview
        11.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 China Isotope & Radiation Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 China Isotope & Radiation Recent Developments
    11.4 Q BioMed
        11.4.1 Q BioMed Corporation Information
        11.4.2 Q BioMed Overview
        11.4.3 Q BioMed Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Q BioMed Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Q BioMed Recent Developments
    11.5 Curium Pharmaceuticals
        11.5.1 Curium Pharmaceuticals Corporation Information
        11.5.2 Curium Pharmaceuticals Overview
        11.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Curium Pharmaceuticals Recent Developments
    11.6 Jubilant DraxImage
        11.6.1 Jubilant DraxImage Corporation Information
        11.6.2 Jubilant DraxImage Overview
        11.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Jubilant DraxImage Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Jubilant DraxImage Recent Developments
    11.7 Dongcheng
        11.7.1 Dongcheng Corporation Information
        11.7.2 Dongcheng Overview
        11.7.3 Dongcheng Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Dongcheng Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Dongcheng Recent Developments
    11.8 Lantheus
        11.8.1 Lantheus Corporation Information
        11.8.2 Lantheus Overview
        11.8.3 Lantheus Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Lantheus Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Lantheus Recent Developments
    11.9 Acrotech Biopharma.
        11.9.1 Acrotech Biopharma. Corporation Information
        11.9.2 Acrotech Biopharma. Overview
        11.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Acrotech Biopharma. Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Acrotech Biopharma. Recent Developments
    11.10 Progenics Pharmaceuticals
        11.10.1 Progenics Pharmaceuticals Corporation Information
        11.10.2 Progenics Pharmaceuticals Overview
        11.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Progenics Pharmaceuticals Recent Developments
    11.11 International Isotopes
        11.11.1 International Isotopes Corporation Information
        11.11.2 International Isotopes Overview
        11.11.3 International Isotopes Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 International Isotopes Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 International Isotopes Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Therapeutic Nuclear Medicines Industry Chain Analysis
    12.2 Therapeutic Nuclear Medicines Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Therapeutic Nuclear Medicines Production Mode & Process
    12.4 Therapeutic Nuclear Medicines Sales and Marketing
        12.4.1 Therapeutic Nuclear Medicines Sales Channels
        12.4.2 Therapeutic Nuclear Medicines Distributors
    12.5 Therapeutic Nuclear Medicines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Therapeutic Nuclear Medicines Industry Trends
    13.2 Therapeutic Nuclear Medicines Market Drivers
    13.3 Therapeutic Nuclear Medicines Market Challenges
    13.4 Therapeutic Nuclear Medicines Market Restraints
14 Key Findings in The Global Therapeutic Nuclear Medicines Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Radium-223
    Table 3. Major Manufacturers of Lutetium-177
    Table 4. Major Manufacturers of Iodine-131
    Table 5. Major Manufacturers of Other
    Table 6. Global Therapeutic Nuclear Medicines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Therapeutic Nuclear Medicines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Therapeutic Nuclear Medicines Sales by Region (2017-2022) & (K Units)
    Table 9. Global Therapeutic Nuclear Medicines Sales Market Share by Region (2017-2022)
    Table 10. Global Therapeutic Nuclear Medicines Sales by Region (2023-2028) & (K Units)
    Table 11. Global Therapeutic Nuclear Medicines Sales Market Share by Region (2023-2028)
    Table 12. Global Therapeutic Nuclear Medicines Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2017-2022)
    Table 14. Global Therapeutic Nuclear Medicines Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2023-2028)
    Table 16. Global Therapeutic Nuclear Medicines Sales by Manufacturers (2017-2022) & (K Units)
    Table 17. Global Therapeutic Nuclear Medicines Sales Share by Manufacturers (2017-2022)
    Table 18. Global Therapeutic Nuclear Medicines Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2017-2022)
    Table 20. Therapeutic Nuclear Medicines Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 21. Global Therapeutic Nuclear Medicines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Therapeutic Nuclear Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Nuclear Medicines as of 2021)
    Table 23. Therapeutic Nuclear Medicines Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Therapeutic Nuclear Medicines Product Offered
    Table 25. Date of Manufacturers Enter into Therapeutic Nuclear Medicines Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Therapeutic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
    Table 28. Global Therapeutic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
    Table 29. Global Therapeutic Nuclear Medicines Sales Share by Type (2017-2022)
    Table 30. Global Therapeutic Nuclear Medicines Sales Share by Type (2023-2028)
    Table 31. Global Therapeutic Nuclear Medicines Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Therapeutic Nuclear Medicines Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Therapeutic Nuclear Medicines Revenue Share by Type (2017-2022)
    Table 34. Global Therapeutic Nuclear Medicines Revenue Share by Type (2023-2028)
    Table 35. Therapeutic Nuclear Medicines Price by Type (2017-2022) & (USD/Unit)
    Table 36. Global Therapeutic Nuclear Medicines Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 37. Global Therapeutic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
    Table 38. Global Therapeutic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
    Table 39. Global Therapeutic Nuclear Medicines Sales Share by Application (2017-2022)
    Table 40. Global Therapeutic Nuclear Medicines Sales Share by Application (2023-2028)
    Table 41. Global Therapeutic Nuclear Medicines Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Therapeutic Nuclear Medicines Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Therapeutic Nuclear Medicines Revenue Share by Application (2017-2022)
    Table 44. Global Therapeutic Nuclear Medicines Revenue Share by Application (2023-2028)
    Table 45. Therapeutic Nuclear Medicines Price by Application (2017-2022) & (USD/Unit)
    Table 46. Global Therapeutic Nuclear Medicines Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 47. North America Therapeutic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
    Table 48. North America Therapeutic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
    Table 49. North America Therapeutic Nuclear Medicines Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Therapeutic Nuclear Medicines Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Therapeutic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
    Table 52. North America Therapeutic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
    Table 53. North America Therapeutic Nuclear Medicines Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Therapeutic Nuclear Medicines Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Therapeutic Nuclear Medicines Sales by Country (2017-2022) & (K Units)
    Table 56. North America Therapeutic Nuclear Medicines Sales by Country (2023-2028) & (K Units)
    Table 57. North America Therapeutic Nuclear Medicines Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Therapeutic Nuclear Medicines Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Therapeutic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
    Table 60. Europe Therapeutic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
    Table 61. Europe Therapeutic Nuclear Medicines Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Therapeutic Nuclear Medicines Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Therapeutic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
    Table 64. Europe Therapeutic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
    Table 65. Europe Therapeutic Nuclear Medicines Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Therapeutic Nuclear Medicines Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Therapeutic Nuclear Medicines Sales by Country (2017-2022) & (K Units)
    Table 68. Europe Therapeutic Nuclear Medicines Sales by Country (2023-2028) & (K Units)
    Table 69. Europe Therapeutic Nuclear Medicines Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Therapeutic Nuclear Medicines Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Therapeutic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
    Table 72. Asia Pacific Therapeutic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
    Table 73. Asia Pacific Therapeutic Nuclear Medicines Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Therapeutic Nuclear Medicines Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Therapeutic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
    Table 76. Asia Pacific Therapeutic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
    Table 77. Asia Pacific Therapeutic Nuclear Medicines Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Therapeutic Nuclear Medicines Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Therapeutic Nuclear Medicines Sales by Region (2017-2022) & (K Units)
    Table 80. Asia Pacific Therapeutic Nuclear Medicines Sales by Region (2023-2028) & (K Units)
    Table 81. Asia Pacific Therapeutic Nuclear Medicines Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Therapeutic Nuclear Medicines Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Therapeutic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
    Table 84. Latin America Therapeutic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
    Table 85. Latin America Therapeutic Nuclear Medicines Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Therapeutic Nuclear Medicines Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Therapeutic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
    Table 88. Latin America Therapeutic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
    Table 89. Latin America Therapeutic Nuclear Medicines Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Therapeutic Nuclear Medicines Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Therapeutic Nuclear Medicines Sales by Country (2017-2022) & (K Units)
    Table 92. Latin America Therapeutic Nuclear Medicines Sales by Country (2023-2028) & (K Units)
    Table 93. Latin America Therapeutic Nuclear Medicines Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Therapeutic Nuclear Medicines Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Therapeutic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
    Table 96. Middle East and Africa Therapeutic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
    Table 97. Middle East and Africa Therapeutic Nuclear Medicines Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Therapeutic Nuclear Medicines Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Therapeutic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
    Table 100. Middle East and Africa Therapeutic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
    Table 101. Middle East and Africa Therapeutic Nuclear Medicines Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Therapeutic Nuclear Medicines Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Therapeutic Nuclear Medicines Sales by Country (2017-2022) & (K Units)
    Table 104. Middle East and Africa Therapeutic Nuclear Medicines Sales by Country (2023-2028) & (K Units)
    Table 105. Middle East and Africa Therapeutic Nuclear Medicines Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Therapeutic Nuclear Medicines Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Novartis AG Corporation Information
    Table 108. Novartis AG Description and Major Businesses
    Table 109. Novartis AG Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 110. Novartis AG Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Novartis AG Recent Developments
    Table 112. Bayer Corporation Information
    Table 113. Bayer Description and Major Businesses
    Table 114. Bayer Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 115. Bayer Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Bayer Recent Developments
    Table 117. China Isotope & Radiation Corporation Information
    Table 118. China Isotope & Radiation Description and Major Businesses
    Table 119. China Isotope & Radiation Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 120. China Isotope & Radiation Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. China Isotope & Radiation Recent Developments
    Table 122. Q BioMed Corporation Information
    Table 123. Q BioMed Description and Major Businesses
    Table 124. Q BioMed Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 125. Q BioMed Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Q BioMed Recent Developments
    Table 127. Curium Pharmaceuticals Corporation Information
    Table 128. Curium Pharmaceuticals Description and Major Businesses
    Table 129. Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 130. Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Curium Pharmaceuticals Recent Developments
    Table 132. Jubilant DraxImage Corporation Information
    Table 133. Jubilant DraxImage Description and Major Businesses
    Table 134. Jubilant DraxImage Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 135. Jubilant DraxImage Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Jubilant DraxImage Recent Developments
    Table 137. Dongcheng Corporation Information
    Table 138. Dongcheng Description and Major Businesses
    Table 139. Dongcheng Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 140. Dongcheng Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Dongcheng Recent Developments
    Table 142. Lantheus Corporation Information
    Table 143. Lantheus Description and Major Businesses
    Table 144. Lantheus Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 145. Lantheus Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Lantheus Recent Developments
    Table 147. Acrotech Biopharma. Corporation Information
    Table 148. Acrotech Biopharma. Description and Major Businesses
    Table 149. Acrotech Biopharma. Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 150. Acrotech Biopharma. Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Acrotech Biopharma. Recent Developments
    Table 152. Progenics Pharmaceuticals Corporation Information
    Table 153. Progenics Pharmaceuticals Description and Major Businesses
    Table 154. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 155. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Progenics Pharmaceuticals Recent Developments
    Table 157. International Isotopes Corporation Information
    Table 158. International Isotopes Description and Major Businesses
    Table 159. International Isotopes Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 160. International Isotopes Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. International Isotopes Recent Developments
    Table 162. Key Raw Materials Lists
    Table 163. Raw Materials Key Suppliers Lists
    Table 164. Therapeutic Nuclear Medicines Distributors List
    Table 165. Therapeutic Nuclear Medicines Customers List
    Table 166. Therapeutic Nuclear Medicines Market Trends
    Table 167. Therapeutic Nuclear Medicines Market Drivers
    Table 168. Therapeutic Nuclear Medicines Market Challenges
    Table 169. Therapeutic Nuclear Medicines Market Restraints
    Table 170. Research Programs/Design for This Report
    Table 171. Key Data Information from Secondary Sources
    Table 172. Key Data Information from Primary Sources
List of Figures
    Figure 1. Therapeutic Nuclear Medicines Product Picture
    Figure 3. Global Therapeutic Nuclear Medicines Market Share by Type in 2021 & 2028
    Figure 3. Radium-223 Product Picture
    Figure 4. Lutetium-177 Product Picture
    Figure 5. Iodine-131 Product Picture
    Figure 6. Other Product Picture
    Figure 7. Global Therapeutic Nuclear Medicines Market Share by Application in 2021 & 2028
    Figure 8. Thyroid
    Figure 9. Bone Metastasis
    Figure 10. Lymphoma
    Figure 11. Other
    Figure 12. Therapeutic Nuclear Medicines Report Years Considered
    Figure 13. Global Therapeutic Nuclear Medicines Sales 2017-2028 (K Units)
    Figure 14. Global Therapeutic Nuclear Medicines Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Therapeutic Nuclear Medicines Revenue 2017-2028 (US$ Million)
    Figure 16. Global Therapeutic Nuclear Medicines Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global Therapeutic Nuclear Medicines Sales Market Share by Region (2017-2022)
    Figure 18. Global Therapeutic Nuclear Medicines Sales Market Share by Region (2023-2028)
    Figure 19. North America Therapeutic Nuclear Medicines Sales YoY (2017-2028) & (K Units)
    Figure 20. North America Therapeutic Nuclear Medicines Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Therapeutic Nuclear Medicines Sales YoY (2017-2028) & (K Units)
    Figure 22. Europe Therapeutic Nuclear Medicines Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Asia-Pacific Therapeutic Nuclear Medicines Sales YoY (2017-2028) & (K Units)
    Figure 24. Asia-Pacific Therapeutic Nuclear Medicines Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Latin America Therapeutic Nuclear Medicines Sales YoY (2017-2028) & (K Units)
    Figure 26. Latin America Therapeutic Nuclear Medicines Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Middle East & Africa Therapeutic Nuclear Medicines Sales YoY (2017-2028) & (K Units)
    Figure 28. Middle East & Africa Therapeutic Nuclear Medicines Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. The Therapeutic Nuclear Medicines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 30. The Top 5 and 10 Largest Manufacturers of Therapeutic Nuclear Medicines in the World: Market Share by Therapeutic Nuclear Medicines Revenue in 2021
    Figure 31. Global Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 32. Global Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2028)
    Figure 33. Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2017-2028)
    Figure 34. Global Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2028)
    Figure 35. Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2017-2028)
    Figure 36. North America Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2028)
    Figure 37. North America Therapeutic Nuclear Medicines Revenue Market Share by Type (2017-2028)
    Figure 38. North America Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2028)
    Figure 39. North America Therapeutic Nuclear Medicines Revenue Market Share by Application (2017-2028)
    Figure 40. North America Therapeutic Nuclear Medicines Sales Share by Country (2017-2028)
    Figure 41. North America Therapeutic Nuclear Medicines Revenue Share by Country (2017-2028)
    Figure 42. U.S. Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 43. Canada Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 44. Europe Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2028)
    Figure 45. Europe Therapeutic Nuclear Medicines Revenue Market Share by Type (2017-2028)
    Figure 46. Europe Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2028)
    Figure 47. Europe Therapeutic Nuclear Medicines Revenue Market Share by Application (2017-2028)
    Figure 48. Europe Therapeutic Nuclear Medicines Sales Share by Country (2017-2028)
    Figure 49. Europe Therapeutic Nuclear Medicines Revenue Share by Country (2017-2028)
    Figure 50. Germany Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 51. France Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 52. U.K. Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 53. Italy Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 54. Russia Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 55. Asia Pacific Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Therapeutic Nuclear Medicines Revenue Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Therapeutic Nuclear Medicines Revenue Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Therapeutic Nuclear Medicines Sales Share by Region (2017-2028)
    Figure 60. Asia Pacific Therapeutic Nuclear Medicines Revenue Share by Region (2017-2028)
    Figure 61. China Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 62. Japan Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 63. South Korea Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 64. India Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 65. Australia Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 66. Taiwan Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 67. Indonesia Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 68. Thailand Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 69. Malaysia Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 70. Philippines Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 71. Latin America Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2028)
    Figure 72. Latin America Therapeutic Nuclear Medicines Revenue Market Share by Type (2017-2028)
    Figure 73. Latin America Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2028)
    Figure 74. Latin America Therapeutic Nuclear Medicines Revenue Market Share by Application (2017-2028)
    Figure 75. Latin America Therapeutic Nuclear Medicines Sales Share by Country (2017-2028)
    Figure 76. Latin America Therapeutic Nuclear Medicines Revenue Share by Country (2017-2028)
    Figure 77. Mexico Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 78. Brazil Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 79. Argentina Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Therapeutic Nuclear Medicines Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Therapeutic Nuclear Medicines Revenue Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Therapeutic Nuclear Medicines Sales Share by Country (2017-2028)
    Figure 85. Middle East and Africa Therapeutic Nuclear Medicines Revenue Share by Country (2017-2028)
    Figure 86. Turkey Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 87. Saudi Arabia Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 88. UAE Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 89. Therapeutic Nuclear Medicines Value Chain
    Figure 90. Therapeutic Nuclear Medicines Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed